Literature DB >> 22612847

Local recurrence and assessment of sentinel lymph node biopsy in deep soft tissue leiomyosarcoma of the extremities.

Michael J Lamyman, Hank P Giele, Paul Critchley, Duncan Whitwell, Max Gibbons, Nick A Athanasou.   

Abstract

BACKGROUND: Leiomyosarcoma of deep soft tissues of the extremities is a rare malignant tumour treated primarily by surgery. The incidence of local recurrence and lymph node metastasis is uncertain and it is not known whether a sentinel lymph node biopsy is indicated in these tumours.
METHODS: A retrospective review of patients treated for extremity deep soft tissue leiomyosarcoma at our institution over a 10-year period was conducted. Patients developing local recurrence or lymph node metastasis were identified. The presence or absence of lymphatics in the primary tumours was assessed by immunohistochemical expression of LYVE-1 and podoplanin.
RESULTS: 27 patients (mean age 62 years) were included in the study. 15 were female and 12 male. Lymph node metastasis was seen in only two cases (7%); intratumoural lymphatics were identified in the primary tumours of both these cases. Local recurrence occurred in 25.9% of cases despite complete excision and post-operative radiotherapy; the mean time to recurrence was 10.1 months.
CONCLUSION: On the basis of this study, we do not advocate sentinel lymph node biopsy in this group of patients except in those cases in which intratumoural lymphatics can be demonstrated. Close follow up is important especially for high grade leiomyosarcomas, particularly in the first year, as these tumours have a high incidence of local recurrence.

Entities:  

Year:  2011        PMID: 22612847      PMCID: PMC3351718          DOI: 10.1186/2045-3329-1-7

Source DB:  PubMed          Journal:  Clin Sarcoma Res        ISSN: 2045-3329


  16 in total

Review 1.  Diagnosis, classification, and management of soft tissue sarcomas.

Authors:  Henry J Mankin; Francis J Hornicek
Journal:  Cancer Control       Date:  2005 Jan-Feb       Impact factor: 3.302

2.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Authors:  C M Balch; S J Soong; J E Gershenwald; J F Thompson; D S Reintgen; N Cascinelli; M Urist; K M McMasters; M I Ross; J M Kirkwood; M B Atkins; J A Thompson; D G Coit; D Byrd; R Desmond; Y Zhang; P Y Liu; G H Lyman; A Morabito
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

3.  The rationale for sentinel-node biopsy in primary melanoma.

Authors:  Donald L Morton; Alistair J Cochran; John F Thompson
Journal:  Nat Clin Pract Oncol       Date:  2008-09

Review 4.  Lymph nodes as sites of metastases from sarcomas of soft tissue.

Authors:  J J Mazeron; H D Suit
Journal:  Cancer       Date:  1987-10-15       Impact factor: 6.860

5.  Sentinel lymph node biopsy in the pediatric population.

Authors:  Kenneth W Gow; Louis B Rapkin; Thomas A Olson; Megan M Durham; Brad Wyly; Bahig M Shehata
Journal:  J Pediatr Surg       Date:  2008-12       Impact factor: 2.545

6.  Leiomyosarcoma of the external soft tissues. A clinicopathologic, immunohistochemical, and electron microscopic study.

Authors:  H Hashimoto; Y Daimaru; M Tsuneyoshi; M Enjoji
Journal:  Cancer       Date:  1986-05-15       Impact factor: 6.860

7.  Experience with 31 sentinel lymph node biopsies for sarcomas and carcinomas in pediatric patients.

Authors:  Mark L Kayton; Ruby Delgado; Klaus Busam; Hiram S Cody; Edward A Athanasian; Daniel Coit; Michael P La Quaglia
Journal:  Cancer       Date:  2008-05-01       Impact factor: 6.860

8.  Early lymphatic spread of osteogenic and soft-tissue sarcomas.

Authors:  D N Weingrad; S A Rosenberg
Journal:  Surgery       Date:  1978-08       Impact factor: 3.982

9.  Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomas.

Authors:  Ugwuji N Maduekwe; Francis J Hornicek; Dempsey S Springfield; Kevin A Raskin; David C Harmon; Edwin Choy; Andrew E Rosenberg; G Petur Nielsen; Thomas F DeLaney; Yen-Lin Chen; Mark J Ott; Sam S Yoon
Journal:  Ann Surg Oncol       Date:  2009-03-04       Impact factor: 5.344

10.  Intratumoural lymphatics in benign and malignant soft tissue tumours.

Authors:  G Mahendra; K Kliskey; K Williams; K Hollowood; D Jackson; N A Athanasou
Journal:  Virchows Arch       Date:  2008-09-24       Impact factor: 4.064

View more
  1 in total

1.  Tumour angiogenesis in Epstein-Barr virus-associated post-transplant smooth muscle tumours.

Authors:  Danny Jonigk; Nicole Izykowski; Lavinia Maegel; Eileen Schormann; Britta Ludewig; Hans Kreipe; Kais Hussein
Journal:  Clin Sarcoma Res       Date:  2014-01-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.